Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Reduced Intensity Reinduction Followed By Blinatumomab Achieves Excellent MRD Clearance with Reduced Toxicity and Facilitates Timely Transplant in Children and Young People with Relapsed B-Precursor Acute Lymphoblastic Leukemia

Blood (2022) 140 (Supplement 1): 3268–3270.

https://doi.org/10.1182/blood-2022-162565

Published: 2022

Journal Articles

Systematic Intention to Treat Analysis of Real-World Outcomes in Children and Young Adults Receiving Tisagenlecleucel: From Elegibility through Treatment Failure

Blood (2022) 140 (Supplement 1): 2408–2410.

https://doi.org/10.1182/blood-2022-162863

Published: 2022

Journal Articles

Dual Antigen Targeting with Co-Transduced CD19/22 CAR T Cells May Prevent Antigen-Negative Relapse after CAR T Cell Therapy for Relapsed/Refractory ALL

Blood (2022) 140 (Supplement 1): 10352–10354.

https://doi.org/10.1182/blood-2022-164879

Published: 2022

Journal Articles

Intention to Treat Analysis of Real-World Outcomes Following Tisgenlecleucel Therapy for Pediatric and Young Adult ALL through a National Access Programme

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-138438

Published: 2020

Journal Articles

Utility of FDG-PET/CT in Lymphoblastic Lymphoma

Thomas A Fox, BSc, MSc, MRCP, Ben Carpenter, PhD, Asim Khwaja, Richard Halsey, MRCP, Victoria Grandage, Marc R. Mansour, MD PhD FRCPath, Adele K. Fielding, MBBS,PhDFRCP,FRCPath, Rachael E Hough, MD

Blood (2019) 134 (Supplement_1): 2890.

https://doi.org/10.1182/blood-2019-127379

Published: 2019

Journal Articles

Therapy of Paediatric B-ALL with a Fast Off Rate CD19 CAR Leads to Enhanced Expansion and Prolonged CAR T Cell Persistence in Patients with Low Bone Marrow Tumour Burden, and Is Associated with a Favourable Toxicity Profile

Blood (2019) 134 (Supplement_1): 225.

https://doi.org/10.1182/blood-2019-125009

Published: 2019

Journal Articles

Major Deviations in the Delivery of Induction Chemotherapy Are Associated with an Increased Risk of Relapse in Acute Lymphoblastic Leukaemia: Results from UKALL2003

Rachael E Hough, MD, Amy A Kirkwood, Sujith Samarasinghe, Clare J Rowntree, MBBS, PhD FRCP, FRCPath, Nicholas John Goulden, MD PhD MRCPath, Ajay Vora

Blood (2019) 134 (Supplement_1): 2579.

https://doi.org/10.1182/blood-2019-127223

Published: 2019

Journal Articles

Phase I Study of AUTO3, a Bicistronic Chimeric Antigen Receptor (CAR) T-Cell Therapy Targeting CD19 and CD22, in Pediatric Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-ALL): Amelia Study

Persis J Amrolia, FRCP, FRCPath, PhD, Robert Wynn, MD, Rachael E Hough, MD, Ajay Vora, Denise Bonney, Paul Veys, MD PhD, Robert Chiesa, Kanchan Rao, Liz Clark, Muhammad Al-Hajj, Shaun P Cordoba, PhD, Shimobi Onuoha, PhD, Ekaterini Kotsopoulou, Nushmia Z Khokhar, Martin Pule, MD, Vijay G R Peddareddigari

Blood (2019) 134 (Supplement_1): 2620.

https://doi.org/10.1182/blood-2019-123424

Published: 2019

Journal Articles

Improved Outcome for Children and Young People with T-Acute Lymphoblastic Leukaemia: Results of the UKALL 2003 Trial

Katharine Patrick, Rachel Wade, Nicholas Goulden, MD PhD, Chris Mitchell, Clare Rowntree, FRCPath, Jeremy Hancock, Rachael E Hough, MD, Ajay J. Vora, FRCPath

Blood (2014) 124 (21): 3702.

https://doi.org/10.1182/blood.V124.21.3702.3702

Published: 2014

Journal Articles

Similar Outcome of Upfront Unrelated and Matched Sibling Donor Hematopoietic Stem Cell Transplantation in Idiopathic Aplastic Anaemia of Childhood and Adolescence: A Cohort Controlled Study on Behalf of the UK Paediatric BMT WP, of the PD WP and of the SAA WP of the EBMT

Blood (2014) 124 (21): 256.

https://doi.org/10.1182/blood.V124.21.256.256

Published: 2014

Journal Articles

Unrelated Cord Blood Transplantation (UCBT) In Adults In The UK: Evolution, Experience and Outcomes. A Retrospective Analysis On Behalf Of The British Society of Blood and Marrow Transplantation (BSBMT) and Eurocord

John A Snowden, MD, FRCP, FRCPath, Robert Danby, MRCP, Annalisa Ruggeri, MD, David I Marks, Rachael E Hough, MD, Antonio Pagliuca, Michael Potter, MD PhD, Nigel Russell, MD, Charles Craddock, MD DPhil, Andrew Clark, Eliane Gluckman, MD, Gordon Cook, MD, PhD, Bronwen E. Shaw, MBChB, MRCP, PhD, FRCPath, Vanderson Rocha, MD, PhD

Blood (2013) 122 (21): 3394.

https://doi.org/10.1182/blood.V122.21.3394.3394

Published: 2013

Journal Articles

Cytomegalovirus Drives Mixed Chimerism Following T-Cell Depleted Allogeneic HSCT, Providing Protective Immunity In The Absence Of GvHD

Rob S Sellar, MBBS, Frederick Arce Vargas, PhD, Jake Henry, Simon Thomas, PhD, Alka Stansfield, Stephanie Verfuerth, PhD, Sarah C Charrot, MBBS, Rachael E Hough, MD, Sergio A Quezada, PhD, Kirsty J Thomson, MD, Stephen Mackinnon, MD, Karl S Peggs, MD

Blood (2013) 122 (21): 4524.

https://doi.org/10.1182/blood.V122.21.4524.4524

Published: 2013

Journal Articles

Barriers To Clinical Trial Enrolment For Teenagers and Young Adults With Acute Lymphoblastic Leukaemia: The Impact of Age Eligibility Criteria

Lorna Anne Fern, BSc, MSc, PhD, Clare Rowntree, PhD, Rachael E Hough, MD, Ajay J Vora, Adele Fielding, MB BS, PhD, Chris Mitchell, Nicholas Goulden, Robert Alston, PhD, Jillian Birch, MD, O'hara Catherine, PhD, Jeremy Whelan, MD FRCP

Blood (2013) 122 (21): 1401.

https://doi.org/10.1182/blood.V122.21.1401.1401

Published: 2013

Journal Articles

Impact Of Age On Toxicity Associated With Chemotherapy For Acute Lymphoblastic Leukaemia (ALL): Results From The UK Prospective Study UKALL2003

Rachael E. Hough, MD, Clare Rowntree, Rachel Wade, Nicholas Goulden, Chris Mitchell, Ajay J. Vora

Blood (2013) 122 (21): 840.

https://doi.org/10.1182/blood.V122.21.840.840

Published: 2013

Journal Articles

Characteristics and Outcome Of Children and Young Adults With Early T-Precusor (ETP) ALL Treated On UKALL 2003

Katharine Patrick, FRCPath, Rachel Wade, Nicholas Goulden, Chris Mitchell, PhD, Clare Rowntree, FRCPath, Rachael E Hough, MD, Ajay J Vora

Blood (2013) 122 (21): 58.

https://doi.org/10.1182/blood.V122.21.58.58

Published: 2013

Journal Articles

Early Multilineage Chimerism Predicts The ‘Winning’ Unit In Double Cord Blood Transplantation

Rachael E Hough, MD, Bronwen E. Shaw, MBChB, MRCP, PhD, FRCPath, Pip Patrick, Nigel Russell, MD, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Charles F. Craddock, BM, MRCP, MRCPath, Eleni Tholouli, Gordon Cook, MD, PhD, David I Marks

Blood (2013) 122 (21): 300.

https://doi.org/10.1182/blood.V122.21.300.300

Published: 2013

Journal Articles

Outcomes Of Teenagers and Young Adults On The UKALL 2003 Paediatric Trial For Children and Young People With Acute Lymphoblastic Leukaemia

Clare Rowntree, PhD, Rachael E Hough, MD, Rachel Wade, Nicholas Goulden, Chris Mitchell, PhD, Ajay J Vora

Blood (2013) 122 (21): 57.

https://doi.org/10.1182/blood.V122.21.57.57

Published: 2013

NARROW

Reduced Intensity Reinduction Followed By Blinatumomab Achieves Excellent MRD Clearance with Reduced Toxicity and Facilitates Timely Transplant in Children and Young People with Relapsed B-Precursor Acute Lymphoblastic Leukemia

Systematic Intention to Treat Analysis of Real-World Outcomes in Children and Young Adults Receiving Tisagenlecleucel: From Elegibility through Treatment Failure

Dual Antigen Targeting with Co-Transduced CD19/22 CAR T Cells May Prevent Antigen-Negative Relapse after CAR T Cell Therapy for Relapsed/Refractory ALL

Intention to Treat Analysis of Real-World Outcomes Following Tisgenlecleucel Therapy for Pediatric and Young Adult ALL through a National Access Programme

Utility of FDG-PET/CT in Lymphoblastic Lymphoma

Therapy of Paediatric B-ALL with a Fast Off Rate CD19 CAR Leads to Enhanced Expansion and Prolonged CAR T Cell Persistence in Patients with Low Bone Marrow Tumour Burden, and Is Associated with a Favourable Toxicity Profile

Major Deviations in the Delivery of Induction Chemotherapy Are Associated with an Increased Risk of Relapse in Acute Lymphoblastic Leukaemia: Results from UKALL2003

Phase I Study of AUTO3, a Bicistronic Chimeric Antigen Receptor (CAR) T-Cell Therapy Targeting CD19 and CD22, in Pediatric Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-ALL): Amelia Study

Improved Outcome for Children and Young People with T-Acute Lymphoblastic Leukaemia: Results of the UKALL 2003 Trial

Similar Outcome of Upfront Unrelated and Matched Sibling Donor Hematopoietic Stem Cell Transplantation in Idiopathic Aplastic Anaemia of Childhood and Adolescence: A Cohort Controlled Study on Behalf of the UK Paediatric BMT WP, of the PD WP and of the SAA WP of the EBMT

Unrelated Cord Blood Transplantation (UCBT) In Adults In The UK: Evolution, Experience and Outcomes. A Retrospective Analysis On Behalf Of The British Society of Blood and Marrow Transplantation (BSBMT) and Eurocord

Cytomegalovirus Drives Mixed Chimerism Following T-Cell Depleted Allogeneic HSCT, Providing Protective Immunity In The Absence Of GvHD

Barriers To Clinical Trial Enrolment For Teenagers and Young Adults With Acute Lymphoblastic Leukaemia: The Impact of Age Eligibility Criteria

Impact Of Age On Toxicity Associated With Chemotherapy For Acute Lymphoblastic Leukaemia (ALL): Results From The UK Prospective Study UKALL2003

Characteristics and Outcome Of Children and Young Adults With Early T-Precusor (ETP) ALL Treated On UKALL 2003

Early Multilineage Chimerism Predicts The ‘Winning’ Unit In Double Cord Blood Transplantation

Outcomes Of Teenagers and Young Adults On The UKALL 2003 Paediatric Trial For Children and Young People With Acute Lymphoblastic Leukaemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only